跳至主要内容
临床试验/NL-OMON20632
NL-OMON20632尚未招募不适用

Reirradiation for recurrent lung cancer in the thorax: overall survival, local control, and toxicity: a phase 2 trial

Erasmus MC0 个研究点目标入组 63 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
Erasmus MC
入组人数
63

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Cytological or histological proof of the current tumor: NSCLC or large cell lung cancer with neuro-endocrine differentiation;
  • Current tumor located close (5 cm or less) to the high dose region (50 Gy EQD2 or more) of the previous radiation;

排除标准

  • Pregnancy;
  • Inability to retrieve the previous radiation fields, total dose, dose per fraction and time of first radiation series and DVH of the organs at risk;

研究者

发起方
Erasmus MC

相似试验